|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
increases phosphorylation decreases expression |
ISO |
NDGA increases phosphorylation in liver of high fructose fed rats NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 PMID:26394137 |
RGD:329955565, RGD:329955565 |
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
|
|
G |
Acacb |
acetyl-Coenzyme A carboxylase beta |
decreases expression |
ISO |
NDGA decreases expression of Acacb protein in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 5:114,284,748...114,388,822
Ensembl chr 5:114,284,596...114,388,822
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
increases expression |
ISO |
NDGA increases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
increases phosphorylation |
ISO |
NDGA increases phosphorylation in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
ISO |
NDGA increases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
ISO |
NDGA increases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
decreases expression |
ISO |
NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
|
|
G |
Fabp2 |
fatty acid binding protein 2, intestinal |
increases expression |
ISO |
NDGA increases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 3:122,688,721...122,693,155
Ensembl chr 3:122,688,721...122,693,155
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
ISO |
NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr19:55,056,067...55,115,666
Ensembl chr19:55,055,700...55,115,670
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
increases phosphorylation |
ISO |
NDGA increases phosphorylation in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 7:24,927,683...24,937,276
Ensembl chr 7:24,927,683...24,937,276
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation |
ISO |
NDGA increases phosphorylation in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Mlxipl |
MLX interacting protein-like |
decreases expression |
ISO |
NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 5:135,118,744...135,168,622
Ensembl chr 5:135,118,744...135,167,236
|
|
G |
Mlycd |
malonyl-CoA decarboxylase |
increases expression |
ISO |
NDGA increases expression of Mlycd protein in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 8:120,121,591...120,148,577
Ensembl chr 8:120,121,617...120,137,841
|
|
G |
Pklr |
pyruvate kinase liver and red blood cell |
decreases expression |
ISO |
NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
increases expression |
ISO |
NDGA increases expression of Ppara protein in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
increases phosphorylation |
ISO |
NDGA increases phosphorylation in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087
|
|
G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
decreases expression |
ISO |
NDGA decreases expression of mRNA, protein in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
NDGA decreases expression of mRNA in liver of high fructose fed rats |
RGD |
PMID:26394137 |
RGD:329955565 |
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
|
|
|
G |
Afp |
alpha fetoprotein |
affects binding |
ISO |
Masoprocol binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
decreases phosphorylation |
ISO |
Masoprocol results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:19503098 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alk |
anaplastic lymphoma kinase |
multiple interactions decreases activity |
ISO |
Masoprocol affects the phosphorylation of and affects the activity of ALK protein mutant form Masoprocol results in decreased activity of ALK protein |
CTD |
PMID:19503098 |
|
NCBI chr17:72,174,206...72,911,719
Ensembl chr17:72,175,967...72,911,622
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase |
multiple interactions decreases activity |
ISO |
Masoprocol inhibits the reaction [ALOX12 protein results in increased chemical synthesis of 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] Masoprocol results in decreased activity of ALOX12 protein |
CTD |
PMID:3928952 PMID:6240459 PMID:9258337 PMID:17027136 PMID:23238474 |
|
NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions decreases activity |
ISO |
Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] Masoprocol results in decreased activity of ALOX15 protein [Masoprocol results in decreased activity of ALOX15 protein] which results in increased abundance of 13-hydroxy-9,11-octadecadienoic acid |
CTD |
PMID:15574791 PMID:18984061 |
|
NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
affects response to substance decreases activity multiple interactions |
ISO |
ALOX5 protein affects the susceptibility to Masoprocol Masoprocol results in decreased activity of ALOX5 protein Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] [Masoprocol results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4; [Masoprocol results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid; Masoprocol inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] |
CTD |
PMID:2724698 PMID:2849922 PMID:3928952 PMID:6240459 PMID:10698703 PMID:18083043 PMID:19503098 More...
|
|
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Ar |
androgen receptor |
affects binding |
ISO |
Masoprocol binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions |
ISO |
Masoprocol results in increased expression of BAX protein MYC affects the reaction [Masoprocol results in increased expression of BAX protein] |
CTD |
PMID:15034932 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
[Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein |
CTD |
PMID:17645780 |
|
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions increases activity |
ISO EXP |
Masoprocol results in increased cleavage of CASP3 protein Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased cleavage of and results in increased activity of CASP3 protein]; Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of CASP3 protein] acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Masoprocol results in increased activity of CASP3 protein]; Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP3 protein] [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:10203695 PMID:10653524 PMID:11470254 PMID:15034932 PMID:17645780 PMID:17651887 PMID:18645000 PMID:19503098 PMID:22308955 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases expression |
ISO EXP |
[Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP8 protein] Masoprocol results in increased expression of CASP8 protein |
CTD |
PMID:10203695 PMID:17645780 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Masoprocol results in increased activity of CASP9 protein |
CTD |
PMID:15034932 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] |
CTD |
PMID:18083043 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Masoprocol results in decreased expression of CCND1 protein |
CTD |
PMID:11953870 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cdh1 |
cadherin 1 |
decreases methylation increases expression |
ISO |
Masoprocol results in decreased methylation of CDH1 promoter Masoprocol results in increased expression of CDH1 mRNA; Masoprocol results in increased expression of CDH1 protein |
CTD |
PMID:18418215 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
decreases methylation increases expression |
ISO |
Masoprocol results in decreased methylation of CDKN2A promoter Masoprocol results in increased expression of CDKN2A mRNA; Masoprocol results in increased expression of CDKN2A protein |
CTD |
PMID:18164318 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of CHUK protein modified form] |
CTD |
PMID:17395008 |
|
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Cryab |
crystallin, alpha B |
multiple interactions |
ISO |
Masoprocol promotes the reaction [sodium arsenite results in increased expression of CRYAB mRNA]; Masoprocol promotes the reaction [sodium arsenite results in increased expression of CRYAB protein] |
CTD |
PMID:8591993 |
|
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
|
|
G |
Dio1 |
deiodinase, iodothyronine, type I |
decreases activity |
ISO |
Masoprocol results in decreased activity of DIO1 protein |
CTD |
PMID:30561685 |
|
NCBI chr 4:107,148,662...107,164,365
Ensembl chr 4:107,148,662...107,164,366
|
|
G |
Dio2 |
deiodinase, iodothyronine, type II |
decreases activity |
ISO |
Masoprocol results in decreased activity of DIO2 protein |
CTD |
PMID:30561685 |
|
NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812
|
|
G |
Dio3 |
deiodinase, iodothyronine type III |
decreases activity |
ISO |
Masoprocol results in decreased activity of DIO3 protein |
CTD |
PMID:30561685 |
|
NCBI chr12:110,245,664...110,247,531
Ensembl chr12:110,245,502...110,247,531
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of ERBB2 protein] |
CTD |
PMID:18645000 |
|
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
multiple interactions |
ISO |
Masoprocol binds to and results in increased activity of ESR1 protein |
CTD |
PMID:19063592 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Masoprocol results in increased expression of FAS protein |
CTD |
PMID:17645780 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasl |
Fas ligand |
multiple interactions |
EXP ISO |
Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP3 protein]; Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP8 protein] Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of FASLG protein] |
CTD |
PMID:10203695 PMID:17651887 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of CHUK protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK8 protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of NFKBIA protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of RELA protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK1 protein]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:17395008 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
EXP |
Masoprocol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]] |
CTD |
PMID:10692565 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Fpr1 |
formyl peptide receptor 1 |
decreases activity |
ISO |
Masoprocol results in decreased activity of FPR1 protein |
CTD |
PMID:17520823 |
|
NCBI chr17:18,096,733...18,104,201
Ensembl chr17:18,096,733...18,104,202
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO EXP |
Masoprocol results in increased expression of HMOX1 mRNA; Masoprocol results in increased expression of HMOX1 protein |
CTD |
PMID:18852027 PMID:23942037 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions increases expression increases activity |
ISO |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid inhibits the reaction [Masoprocol results in increased activity of HSD11B2 protein]; 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid inhibits the reaction [Masoprocol results in increased expression of HSD11B2 mRNA]; [Masoprocol co-treated with 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] results in decreased expression of HSD11B2 protein; [Masoprocol co-treated with Leukotriene B4] results in decreased expression of HSD11B2 protein; Leukotriene B4 inhibits the reaction [Masoprocol results in increased activity of HSD11B2 protein]; Masoprocol inhibits the reaction [Progesterone results in decreased activity of HSD11B2 protein]; Masoprocol promotes the reaction [Mifepristone results in increased activity of HSD11B2 protein] |
CTD |
PMID:10377029 PMID:18032417 |
|
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [IGF1 protein promotes the reaction [IGF1R protein results in increased phosphorylation of and results in increased activity of IGF1R protein]]; Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of ERBB2 protein]; Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of IGF1R protein] |
CTD |
PMID:18491370 PMID:18645000 |
|
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
|
|
G |
Igf1r |
insulin-like growth factor I receptor |
multiple interactions decreases activity |
ISO |
Masoprocol inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1R mRNA]; Masoprocol inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1R protein]; Masoprocol inhibits the reaction [IGF1 protein promotes the reaction [IGF1R protein results in increased phosphorylation of and results in increased activity of IGF1R protein]]; Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of IGF1R protein] Masoprocol results in decreased activity of IGF1R protein |
CTD |
PMID:18491370 PMID:18645000 |
|
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases response to substance |
ISO EXP |
Masoprocol inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] Masoprocol results in decreased susceptibility to IL1B protein Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:8186192 PMID:12573452 PMID:21211511 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] |
CTD |
PMID:8186192 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr10:3,490,274...3,504,880
Ensembl chr10:3,490,240...3,504,877
|
|
G |
Jun |
jun proto-oncogene |
decreases expression multiple interactions |
ISO EXP |
Masoprocol results in decreased expression of JUN mRNA Masoprocol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]] |
CTD |
PMID:10692565 PMID:15034932 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] |
CTD |
PMID:18984061 |
|
NCBI chr 6:126,509,514...126,512,518
Ensembl chr 6:126,509,514...126,512,375
|
|
G |
Krt1 |
keratin 1 |
multiple interactions |
EXP |
Masoprocol inhibits the reaction [Calcium results in increased expression of KRT1 mRNA] |
CTD |
PMID:12069687 |
|
NCBI chr15:101,753,861...101,759,221
Ensembl chr15:101,753,861...101,759,229
|
|
G |
Lhb |
luteinizing hormone beta |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [LHB protein results in increased abundance of Cyclic AMP]; Masoprocol inhibits the reaction [LHB protein results in increased abundance of Pregnenolone]; Masoprocol inhibits the reaction [LHB protein results in increased abundance of Testosterone] |
CTD |
PMID:6430271 |
|
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK1 protein] Masoprocol results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:17395008 PMID:19503098 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
decreases phosphorylation multiple interactions |
ISO |
Masoprocol results in decreased phosphorylation of MAPK3 protein Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:17395008 PMID:19503098 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK8 protein modified form] |
CTD |
PMID:17395008 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form] |
CTD |
PMID:17395008 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 protein] |
CTD |
PMID:17395008 PMID:21211511 |
|
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
|
|
G |
Myc |
myelocytomatosis oncogene |
increases expression multiple interactions |
ISO |
Masoprocol results in increased expression of MYC protein MYC affects the reaction [Masoprocol results in increased expression of BAX protein]; MYC affects the reaction [Masoprocol results in increased expression of MYC protein]; MYC affects the reaction [Masoprocol results in increased expression of TP53 protein] |
CTD |
PMID:15034932 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
ISO |
Masoprocol affects the localization of and results in increased activity of NFE2L2 protein |
CTD |
PMID:18852027 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of NFKBIA protein modified form] |
CTD |
PMID:17395008 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGF mRNA]; Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGF protein] |
CTD |
PMID:17651887 |
|
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
|
|
G |
Ngfr |
nerve growth factor receptor (TNFR superfamily, member 16) |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGFR mRNA]; Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGFR protein] |
CTD |
PMID:17651887 |
|
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA] |
CTD |
PMID:22037733 |
|
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Odc1 |
ornithine decarboxylase, structural 1 |
multiple interactions |
EXP |
Masoprocol inhibits the reaction [Benzoyl Peroxide results in increased activity of ODC1 protein] |
CTD |
PMID:2105358 |
|
NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
|
|
G |
Otc |
ornithine transcarbamylase |
multiple interactions |
ISO |
Masoprocol promotes the reaction [PRL protein results in increased activity of OTC protein] |
CTD |
PMID:3097147 |
|
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Masoprocol affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein] |
CTD |
PMID:25770929 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
Masoprocol inhibits the reaction [POR protein affects the reaction [Benzo(a)pyrene results in increased chemical synthesis of benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA]] |
CTD |
PMID:28111842 |
|
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
Masoprocol promotes the reaction [PRL protein results in increased activity of OTC protein] |
CTD |
PMID:3097147 |
|
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]]; Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:7575673 PMID:12573452 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Masoprocol results in decreased phosphorylation of RB1 protein |
CTD |
PMID:18164318 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of RELA protein modified form] |
CTD |
PMID:17395008 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
Masoprocol binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
|
|
G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [TSHB protein results in increased expression of SLC5A5 mRNA] |
CTD |
PMID:17962351 |
|
NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; Masoprocol inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 protein]; Masoprocol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] |
CTD |
PMID:8760145 PMID:12031898 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases phosphorylation |
ISO |
Masoprocol results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:19503098 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TGFB1 mRNA] |
CTD |
PMID:19194550 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases response to substance |
ISO EXP |
Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 protein]; Masoprocol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] Masoprocol results in decreased susceptibility to TNF protein |
CTD |
PMID:8186192 PMID:8760145 PMID:21211511 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
multiple interactions |
ISO |
[Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein; [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP10 protein; [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:17645780 |
|
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions increases expression |
ISO |
MYC affects the reaction [Masoprocol results in increased expression of TP53 protein] |
CTD |
PMID:15034932 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [[Melitten results in increased activity of TRPV1 protein] which results in increased transport of Calcium] |
CTD |
PMID:21453681 |
|
NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
|
|
G |
Tshb |
thyroid stimulating hormone, beta subunit |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [TSHB protein results in increased expression of SLC5A5 mRNA] |
CTD |
PMID:17962351 |
|
NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Masoprocol |
CTD |
PMID:14557274 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
G |
Ugt1a10 |
UDP glycosyltransferase 1 family, polypeptide A10 |
increases glucuronidation |
ISO |
UGT1A10 protein results in increased glucuronidation of Masoprocol |
CTD |
PMID:14557274 |
|
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Masoprocol |
CTD |
PMID:14557274 |
|
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Masoprocol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of VEGFA mRNA]; Masoprocol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of VEGFA protein] |
CTD |
PMID:17520823 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|